Analytical Data
-
Gene name
TCEANC2
- Application
-
Alternative Names
TCEANC2；C1orf83；Transcription elongation factor A N-terminal and central domain-containing Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96MN5
-
Expression Region
1-208aa
-
AA Sequence
MDKFVIRTPRIQNSPQKKDSGGKVYKQATIESLKRVVVVEDIKRWKTMLELPDQTKENLVEALQELKKKIPSREVLKSTRIGHTVNKMRKHSDSEVASLAREVYTEWKTFTEKHSNRPSIEVRSDPKTESLRKNAQKLLSEALELKMDHLLVENIERETFHLCSRLINGPYRRTVRALVFTLKHRAEIRAQVKSGSLPVGTFVQTHKK
-
Molecular Weight
40.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TCEANC2, a member of the TCE (T cell expansion) family, is a recombinant protein that has garnered significant interest in immunology and therapeutic research. The study of TCEANC2 is particularly relevant due to its potential role in modulating T cell responses. Recent advancements in recombinant protein technology have enabled the production of TCEANC2, allowing researchers to investigate its biological functions, interaction mechanisms, and therapeutic applications. Studies suggest that TCEANC2 may influence T cell activation and differentiation, thus offering insights into immune system regulation. Understanding TCEANC2's role could pave the way for novel immunotherapeutic strategies, particularly in the context of autoimmune diseases and cancer treatment. Moreover, the exploration of TCEANC2's structure-function relationships helps elucidate the underlying pathways of T cell modulation, thereby contributing to the broader field of targeted therapies. As research progresses, TCEANC2 holds the promise of being a pivotal factor in enhancing T cell functionality and improving patient outcomes in various immunological disorders.
